How to Read a Peptide Certificate of Analysis (COA)

Updated August 2026. A peptide Certificate of Analysis (COA) is useful only if the information on it is understood in context. A percentage such as “99% purity” can look definitive, but the meaning depends on the analytical method, the sample tested, the batch identifier, the way peaks were integrated, and whether other quality attributes were measured separately.

This guide explains how to read a peptide COA systematically. It focuses on the analytical information most commonly encountered with synthetic research peptides: reversed-phase HPLC, mass spectrometry, batch identification, peptide content, test dates and supporting chromatograms. For a deeper explanation of the analytical techniques themselves, see our guide to peptide purity testing by HPLC and mass spectrometry.

What a Certificate of Analysis Is

A COA is a summary of analytical results for a defined sample or batch. In a well-documented workflow it connects the material being supplied with one or more tests performed on that material. Depending on the laboratory and the product, the certificate may include identity testing, chromatographic purity, peptide content, water, residual solvent, counter-ion, microbiological testing or other attributes.

There is no single universal COA format. The important question is not whether the document looks professional; it is whether the certificate clearly identifies the tested material, the methods used and the results obtained.

1. Start With the Product and Batch Information

Before looking at the purity percentage, check that the certificate actually corresponds to the material of interest. Useful identifiers can include:

• Peptide or product name.
• Sequence or molecular formula, where applicable.
• Lot or batch number.
• Sample or laboratory reference number.
• Strength or nominal quantity, if the test is linked to a specific vial presentation.
• Date received, date tested or report date.

Batch matching matters. A genuine analytical result for one lot does not automatically establish the quality of every later lot of the same peptide. If a supplier presents batch-specific documentation, the batch or sample identifier should make it possible to connect the document to the material being represented.

2. Identify Who Performed the Testing

A COA should make clear whether the analysis was produced by the manufacturer, supplier or an independent analytical laboratory. Independent testing can provide useful separation between the seller and the measurement, but independence alone does not make a result reliable. The analytical method, sample handling, instrument performance and reporting quality still matter.

Look for the laboratory name, report identifier and enough information to establish where the testing originated. A laboratory-generated report may also include analyst approval, electronic signatures, instrument identifiers or accreditation information. Those elements help with traceability, but they should not be confused with the analytical result itself.

3. Understand What “HPLC Purity” Means

For synthetic peptides, reversed-phase high-performance liquid chromatography (RP-HPLC) is commonly used to separate the principal peptide from related impurities. The chromatogram records detector response as compounds elute from the column. A reported value such as 98.7% or 99.3% is often calculated from the integrated area of the main chromatographic peak relative to the total integrated peak area.

That number is best described as chromatographic area purity under the stated method. It is not automatically the same as saying that 99.3% of the total vial mass is peptide.

Water, counter-ions, inorganic salts or other components may not be represented in the same way by a UV HPLC method. In addition, an impurity that co-elutes with the main peptide can contribute to the same apparent peak. Studies of pharmaceutical peptides have specifically shown why orthogonal chromatographic or mass-spectrometric methods may be needed to investigate peak purity and co-eluting species.

What to look for on an HPLC section

• The reported main-peak area percentage.
• A chromatogram rather than only a typed result.
• Retention time of the principal peak.
• An integration table showing the main peak and detected impurity peaks.
• The analytical wavelength, column or method reference where provided.
• Clear axes and a readable chromatographic trace.

A very clean chromatogram is useful evidence, but the result should always be interpreted as a measurement produced by that specific analytical method.

4. Check Whether Mass Spectrometry Confirms Identity

Mass spectrometry (MS) provides a different type of information. Rather than primarily separating peaks by retention behavior, MS measures ions according to their mass-to-charge ratio. For a synthetic peptide with a known expected molecular mass, the observed mass spectrum can provide strong evidence that the major component is consistent with the intended peptide.

Depending on the instrument and reporting format, the certificate may show an observed molecular ion, multiple charge states, a deconvoluted molecular mass, or an LC-MS trace. The important comparison is between the expected mass and the observed mass.

HPLC and MS answer related but different questions:

• HPLC: how much of the chromatographic detector response is associated with the main separated peak?
• MS: is the mass of the major detected species consistent with the expected peptide?

Using both techniques is therefore more informative than relying on either one alone. Current analytical literature on synthetic peptide characterization routinely uses LC-MS because chromatography and mass spectrometry provide complementary separation and identity information.

5. Do Not Confuse Purity With Peptide Content

This is one of the most important distinctions on a peptide COA.

Chromatographic purity describes the relative amount of the main chromatographic component compared with detected chromatographic impurities. Peptide content or mass-fraction purity asks a different question: how much of the weighed material is actually the peptide itself?

A highly purified synthetic peptide can still contain water, counter-ions or other non-peptide material. Accurate value assignment of peptide reference materials may therefore use additional approaches such as amino-acid analysis, quantitative NMR, water determination or a mass-balance strategy. Published work on peptide reference standards makes this distinction explicit.

If a COA reports only “99% by HPLC,” it should not automatically be interpreted as “99% of the physical powder mass is active peptide.” A separate assay or content measurement is required to make that stronger quantitative statement.

6. Look at Test Dates and Document Traceability

Dates provide context. A certificate may list the date the sample was received, the analysis date, approval date or report-issue date. For batch documentation, the date should be plausible relative to the batch being represented.

A report number or sample identifier is also valuable because it gives the analytical laboratory a specific record to reference. If a certificate has been revised, the revision or version information should ideally be visible.

7. Check Whether Acceptance Criteria Are Stated

Some certificates report only the measured result. Others include a specification or acceptance criterion beside it, for example a minimum chromatographic purity or an acceptable molecular-mass range.

A result and a specification are not the same thing. The result tells you what was measured; the specification states the criterion against which that result was judged. In regulated pharmaceutical analysis, analytical procedures are expected to be suitable for their intended purpose, and validation concepts include characteristics such as specificity, accuracy, precision, range and detection or quantitation capability where relevant. ICH Q2(R2) and Q14 provide the modern framework for analytical procedure validation and development.

A research-product COA will not necessarily reproduce the laboratory’s full method-validation package. The absence of that full package does not by itself invalidate a result, but it is useful to understand the difference between a certificate summary and the underlying analytical method documentation.

8. Know What HPLC and MS Do Not Automatically Prove

A peptide certificate showing HPLC and MS results can provide useful evidence of chromatographic purity and molecular identity. It does not, by itself, establish every possible quality attribute.

Unless specifically tested and reported, HPLC/MS results should not be assumed to establish:

• Sterility.
• Bacterial endotoxin level.
• Absence of every possible residual solvent or inorganic contaminant.
• Exact peptide content per vial.
• Long-term stability after the testing date.
• Correct storage or handling after the laboratory received or tested the sample.

Those attributes require their own analytical or microbiological tests when they are relevant to the intended application.

9. Read the Chromatogram and Spectrum, Not Just the Headline Number

When supporting data are supplied, look beyond the headline result. A chromatogram can reveal whether the main peak is well resolved and whether smaller peaks are present. A mass spectrum can show whether the expected molecular species dominates and whether additional ions are visible.

Neither image needs to look visually perfect to be meaningful; real analytical data contain baselines, noise and minor signals. What matters is whether the reported interpretation is consistent with the actual data and the stated method.

10. Common COA Warning Signs

No single formatting issue proves that a certificate is unreliable, but several features justify closer scrutiny:

• No batch, lot or sample identifier.
• No testing date or report date.
• No laboratory or testing source identified.
• A purity percentage with no analytical method stated.
• An HPLC result presented with no chromatogram when supporting data would normally be expected.
• A mass-spectrometry result that does not show or state the expected and observed mass.
• The same certificate being presented for materially different batches without explanation.
• A claim that HPLC purity alone proves sterility, exact vial content or every other quality attribute.

A Practical COA Checklist

When reviewing a peptide certificate, a useful sequence is:

1. Confirm the peptide name and batch/sample identifier.
2. Check who performed the analysis and when.
3. Identify the analytical methods used.
4. Read the HPLC result as chromatographic purity, not automatically as total peptide content.
5. Compare expected and observed molecular mass where MS data are reported.
6. Check the chromatogram and spectrum if supplied.
7. Look for a separate peptide-content or assay result if exact mass fraction is important.
8. Do not infer sterility, endotoxin status or other untested attributes from HPLC/MS alone.

COAs in the Context of Research Peptide Purchasing

A COA is one part of evaluating a research peptide supplier. It should be considered alongside clear product identification, batch traceability, transparent pack information and realistic statements about what the analytical data demonstrate.

For general ordering and product-selection information, see the Peptide Buying Guide and our Research Supply Information. To understand the analytical techniques behind many peptide certificates, continue with How Peptide Purity Is Tested: HPLC, Mass Spectrometry and What the Results Mean.

References and Further Reading

• ICH Q2(R2): Validation of Analytical Procedures — FDA.
• ICH Q14: Analytical Procedure Development — FDA.
• Characterization of Synthetic Peptides by Mass Spectrometry.
• Characterization of Synthetic Peptide Therapeutics Using Liquid Chromatography-Mass Spectrometry.
• Identification and Accurate Quantification of Structurally Related Peptide Impurities by LC-HRMS.
• Reference Standards to Support Quality of Synthetic Peptide Therapeutics.
• Analysis of Peptides and Conjugates by Amino Acid Analysis.

Research-use information only. This article discusses analytical interpretation and does not provide medical advice or establish suitability of any material for human use.